| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.479 | 4.551 | 6.080 | 9.191 | 9.265 | 12.616 |
| Total Income - EUR | - | - | - | - | 2.479 | 4.551 | 6.102 | 9.191 | 9.265 | 12.617 |
| Total Expenses - EUR | - | - | - | - | 0 | 79 | 1.975 | 3.149 | 3.631 | 11.319 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.479 | 4.473 | 4.127 | 6.042 | 5.634 | 1.298 |
| Net Profit/Loss - EUR | - | - | - | - | 2.405 | 4.336 | 3.944 | 5.780 | 4.562 | 538 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 2.521 | 6.946 | 10.624 | 11.334 | 10.219 | 8.103 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 20 | 0 | 0 | 760 |
| Cash | - | - | - | - | 2.521 | 6.946 | 10.604 | 11.334 | 10.219 | 7.343 |
| Shareholders Funds | - | - | - | - | 2.447 | 6.737 | 10.532 | 11.008 | 9.674 | 7.316 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 74 | 209 | 92 | 326 | 545 | 787 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biomed Srl